Related Articles
The cyclin-dependent kinase inhibitor flavopiridol sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis
COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis
Enhanced TRAIL sensitivity by p53 overexpression in human cancer but not normal cell lines
Differential susceptibility of gastric cancer cells to TRAIL-induced apoptosis
Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death